Author Question: A meta-analysis (Cuijpers et al., 2011) examining interpersonal psychotherapy (IPT) for depression ... (Read 50 times)

vHAUNG6011

  • Hero Member
  • *****
  • Posts: 514
A meta-analysis (Cuijpers et al., 2011) examining interpersonal psychotherapy (IPT) for depression yielded an overall effect size that was:
 
  a. small. c. large.
  b. medium. d. very large.

Question 2

A recent randomized effectiveness trial of IPT for depressed adolescents (called IPT-
 
  a. showed that:
  a. adolescents treated in school-based clinics had inferior outcomes to those treated in hospital settings.
  b. IPT was about as good as treatment as usual.
  c. IPT was superior to treatment as usual.
  d. adolescents treated with CBT had better outcomes than those treated with IPT and treatment as usual.



javimendoza7

  • Sr. Member
  • ****
  • Posts: 293
Answer to Question 1

B

Answer to Question 2

C



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Stevens-Johnson syndrome and Toxic Epidermal Necrolysis syndrome are life-threatening reactions that can result in death. Complications include permanent blindness, dry-eye syndrome, lung damage, photophobia, asthma, chronic obstructive pulmonary disease, permanent loss of nail beds, scarring of mucous membranes, arthritis, and chronic fatigue syndrome. Many patients' pores scar shut, causing them to retain heat.

Did you know?

In Eastern Europe and Russia, interferon is administered intranasally in varied doses for the common cold and influenza. It is claimed that this treatment can lower the risk of infection by as much as 60–70%.

Did you know?

Cutaneous mucormycosis is a rare fungal infection that has been fatal in at least 29% of cases, and in as many as 83% of cases, depending on the patient's health prior to infection. It has occurred often after natural disasters such as tornados, and early treatment is essential.

Did you know?

There are 60,000 miles of blood vessels in every adult human.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

For a complete list of videos, visit our video library